Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Land & Improvements (2016 - 2018)

Updated

Alnylam Pharmaceuticals (ALNY) recorded Land & Improvements of $9.08 million in Q4 2018, unchanged from $9.08 million a year earlier.

Analysis

Alnylam Pharmaceuticals (ALNY) Land & Improvements (2016 - 2018) Analysis & Trends

  • Across earlier years, Land & Improvements came in at $9.08 million in FY2017 (unchanged) and $9.08 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 9.08 Mn
Dec 31, 2017 9.08 Mn
Dec 31, 2016 9.08 Mn
API Access

Alnylam Pharmaceuticals Land & Improvements API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=land-and-improvements&ticker=ALNY&period=max&api_key=YOUR_API_KEY